May 29, 2019 - Teva (TEVA) plummets after settlement with the state of Oklahoma in a litigation related to its role in opioid epidemic, resulting in a rating downgrade.
May 08, 2019 - Companies In The News Are:
May 07, 2019 - MYL earnings call for the period ending March 31, 2019.
May 07, 2019 - Mylan N.V. (NASDAQ:MYL) Q1 2019 Results Earnings Conference Call May 07, 2019, 10:00 AM ET Company Participants Melissa Trombetta - Head, Global Investor Relations Heather Bresch - CEO Rajiv Malik - P
May 07, 2019 - Mylan's (MYL) earnings beat estimates but sales miss the same in the first quarter of 2019.
May 07, 2019 - Gainers: Bridgeline Digital (NASDAQ:BLIN) +30%. Cohu (NASDAQ:COHU) +27%. ATA (NASDAQ:ATAI) +25%. ARCA biopharma (NASDAQ:ABIO) +24%. SolarEdge Technologies (NASDAQ:SEDG) +23%. Summit Wireless Technolog
May 02, 2019 - Acorda's (ACOR) shares rise on earnings and revenue beat in Q1. Inbrija registers first sales figure following its launch in the reported quarter.
Apr 29, 2019 - Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to hurt Teva's (TEVA) sales in Q1.
Apr 11, 2019 - Acorda (ACOR) aims to boost sales with the launch of its newly FDA-approved Parkinson's disease drug, Inbrija. The company's pipeline looks promising as well.
Mar 28, 2019 - Mylan (MYL) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.